ACTRN12621001263886
Not yet recruiting
未知
A comprehensive invasive assessment of coronary physiology in adult patients with cardiogenic shock
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cardiogenic shock
- Sponsor
- Alfred Health
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Ages of 18 and above.
- •2\. Coronary angiography being undertaken as part of routine patient care as determined by the treating team.
- •3\. SCAI Shock stage C or less
- •4\.Onset of symptoms \<24 hours prior.
- •5\.Measurements to be performed at time of coronary angiography
Exclusion Criteria
- •Pregnant and breastfeeding women, due to the radiation exposure inherent to this study
- •Non\-cardiac cause of shock (e.g. pulmonary embolism, pneumothorax, cardiac tamponade, etc.)
- •Active bleeding
- •Prior coronary artery bypass grafting
- •Mechanical complication of surgery
- •Known left ventricular thrombus
- •Mechanical aortic valve
- •Patients with contraindications to adenosine including: asthma/bronchospasm, greater than first degree heart block or sick sinus syndrome without a pacemaker, symptomatic aortic stenosis or hypertrophic cardiomyopathy, cerebral ischaemia or current dipyridamole medication use.
- •Considered prohibitively hemodynamically unstable (e.g. Noradrenaline dose\>50mcg/min)
- •Prolonged cardiac arrest (in or out\-of\-hospital) \> 20 minutes prior to return of spontaneous circulation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Invasive physiologic assessment of Coronary artery stenosis by rEsting Full-cycLe ratio and fractional flOW resERve: a prospective observational studyDiseases of the circulatory systemKCT0005255Yonsei University Health System, Yongin Severance Hospital200
Completed
Not Applicable
on-invasive Assessment of Coronary Artery Disease in Patients with Chest Pain.Patients with suspected coronary artery diseaseNL-OMON24749100
Completed
Phase 3
High-Resolution Assessment of Coronary Plaques in a Global Evolocumab Randomized Study (HUYGENS)anginaheart attackhigh blood lipidshigh cholesterolVessels supplying the heart with blood1001108210013317NL-OMON48805Amgen43
Active, not recruiting
Phase 1
Imaging of Coronary Plaques in Subjects Treated With EvolocumabEUCTR2017-003236-37-DEAmgen Inc.150
Active, not recruiting
Phase 1
Imaging of Coronary Plaques in Subjects Treated With EvolocumabDyslipidemiaMedDRA version: 20.0Level: PTClassification code 10058108Term: DyslipidaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2017-003236-37-ITAMGEN INC.150